• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

April 27, 2006

View Archived Issues

ALS Association awards research funding to Sirtris

Read More

Safetek signs term sheet with Resdevco

Read More

Dynavax Technologies completes acquisition of Rhein Biotech GmbH

Read More

Apaziquone highly active in superficial bladder cancer

Read More

Teverelix shows promise in phase II prostate cancer study

Read More

Tolterodine improves overactive bladder symptoms and patient quality of life

Read More

SUNRISE study reveals urinary urgency improvement with solifenacin

Read More

hMaxi-K gene transfer for erectile dysfunction safe in phase I study

Read More

Dose proportionality confirmed with BEMA Fentanyl

Read More

Antinociceptive activity of neurotoxin receptor site 2-targeting sodium channel blocker

Read More

Disappointing results from phase III trial of bicifadine in chronic low back pain

Read More

IND approval for Aurora kinase inhibitor AT-9283

Read More

Phase II picoplatin study expanded into Eastern Europe

Read More

Panzem NCD with paclitaxel studied for metastatic breast cancer

Read More

DOD grant supports study of bavituximab in breast cancer

Read More

Enrollment completed in study of Chondrogen to repair tissue in the knee

Read More

PhytoMedical to focus on development of specific polyphenols

Read More

Series B financing at Protez to support development of PZ-601

Read More

Target enrollment completed in phase IIa study of E1-I.N.T. for type 2 diabetes

Read More

New Asian study for Iressa in first-line NSCLC

Read More

Lixivaptan demonstrates aquaretic effects in heart failure patients

Read More

ZT-1 evaluated in vivo, in healthy subjects and in Alzheimer's disease patients

Read More

European approval and recommendation for new Keppra indications

Read More

European approval for Preotact

Read More

Vaprisol launched for treatment of euvolemic hyponatremia

Read More

Roche seeks European approval for novel anemia drug CERA

Read More

Coagulation factor Xa inhibitors prepared and tested at Merck

Read More

Recent Bayer patent imparts novel agents for lipoprotein-related disorders

Read More

Two recent Pfizer patents describe new histamine H3 receptor antagonists

Read More

Newly formed Abraxis Bioscience presents data on nab tumor targeting technology

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe